Occudo Quantitative Strategies’s Eli Lilly LLY Stock Holding History

Occudo Quantitative Strategies’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.64M	Buy	+3,892	New	+$3.95M	0.2%	152
2025 Q4	–	Sell	-1,232	Closed	-$940K	–	822
2025 Q3	$940K	Buy	+1,232	New	+$917K	0.11%	255
2025 Q1	–	Sell	-3,250	Closed	-$2.51M	–	799
2024 Q4	$2.51M	Sell	3,250 -1,142	-26%	-$946K	0.45%	49
2024 Q3	$3.89M	Buy	+4,392	New	+$3.95M	0.71%	27
2022 Q4	–	Sell	-2,631	Closed	-$851K	–	1190
2022 Q3	$851K	Sell	2,631 -2,918	-53%	-$925K	0.07%	467
2022 Q2	$1.8M	Buy	5,549 +3,238	+140%	+$972K	0.15%	207
2022 Q1	$662K	Sell	2,311 -14,369	-86%	-$3.7M	0.06%	535
2021 Q4	$4.61M	Sell	16,680 -1,503	-8%	-$381K	0.41%	37
2021 Q3	$4.2M	Buy	+18,183	New	+$4.49M	0.5%	13
2021 Q2	–	Sell	-1,160	Closed	-$217K	–	978
2021 Q1	$217K	Buy	+1,160	New	+$227K	0.05%	597

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Occudo Quantitative Strategies's LLY Position: Q1 2026 in Review

Occudo Quantitative Strategies opened a new position in Eli Lilly (LLY) in Q1 2026: 3,892 shares worth $3.64M. The stake represents 0.2% of the portfolio and ranks #152 among its holdings. This is a return to the name: Occudo Quantitative Strategies previously reported a position in LLY as recently as Q3 2025.

Occudo Quantitative Strategies first reported a position in LLY in Q1 2021 and has held it in 10 quarters since. The position peaked at $4.61M in Q4 2021. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Occudo Quantitative Strategies held 3,892 shares of Eli Lilly worth $3.64M as of Q1 2026.
Eli Lilly was a new Occudo Quantitative Strategies position in Q1 2026.
Eli Lilly made up 0.2% of Occudo Quantitative Strategies's portfolio in Q1 2026, its #152 holding.
Occudo Quantitative Strategies first reported a position in Eli Lilly in Q1 2021 and has held it in 10 quarters since.
Occudo Quantitative Strategies's Eli Lilly position peaked at $4.61M in Q4 2021.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.